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Protein aggregation is linkedwith neurodegeneration
and numerous other diseases by mechanisms that
are not well understood. Here, we have analyzed
the gain-of-function toxicity of artificial b sheet
proteins that were designed to form amyloid-like
fibrils. Using quantitative proteomics, we found that
the toxicity of these proteins in human cells corre-
lateswith the capacity of their aggregates to promote
aberrant protein interactions and to deregulate the
cytosolic stress response. The endogenous proteins
that are sequestered by the aggregates share
distinct physicochemical properties: They are rela-
tively large in size and significantly enriched in
predicted unstructured regions, features that are
strongly linked with multifunctionality. Many of the
interacting proteins occupy essential hub positions
in cellular protein networks, with key roles in
chromatin organization, transcription, translation,
maintenance of cell architecture and protein quality
control. We suggest that amyloidogenic aggregation
targets a metastable subproteome, thereby causing
multifactorial toxicity and, eventually, the collapse
of essential cellular functions.INTRODUCTION
Themajority of proteins must fold into well-defined three-dimen-
sional structures in order to fulfill their biological functions. This
fundamental process is aided by a complex cellular machinery
of molecular chaperones, which act to prevent misfolding and
aggregation (Frydman, 2001; Hartl and Hayer-Hartl, 2002; Mori-
moto, 2008). Failure of a protein to fold properly, or to retain its
folded state, has emerged as the cause of numerous diseases.
Aberrant folding is often the result of destabilizing mutationsand may cause the loss of critical functions. However, in a
growing number of diseases, misfolding and aggregation results
predominantly in a toxic gain of function (Stefani and Dobson,
2003; Winklhofer et al., 2008). In these disorders, specific
proteins, differing substantially in size and sequence, typically
self-assemble into amyloid-like fibrils with cross-b structure
which are deposited within or outside of cells. This phenomenon
underlies some of the most debilitating neurodegenerative
disorders, including Parkinson’s, Huntington’s, and Alzheimer’s
disease.
Amyloidogenic aggregation is observed with many protein
sequences (Chiti and Dobson, 2006; Goldschmidt et al., 2010)
and is often associated with the accumulation of soluble, oligo-
meric species that precede fibril formation and are thought to
be responsible for toxicity (Campioni et al., 2010; Chiti and
Dobson, 2006; Jahn and Radford, 2008). The underlying mech-
anisms are only poorly understood but a prominent hypothesis
suggests that the aggregates, in particular the more heteroge-
neous oligomers, may expose flexible hydrophobic surfaces
that can mediate aberrant interactions with other proteins,
resulting in their functional impairment and sequestration
(Bolognesi et al., 2010; Chiti and Dobson, 2006). In another
model, misfolding proteins, by engaging the chaperone
machinery, are thought to interfere with central protein quality
control and clearance mechanisms, possibly resulting in a prop-
agation of folding defects (Balch et al., 2008; Bence et al., 2001;
Gidalevitz et al., 2006). Finally, based on experiments with model
membranes, oligomeric aggregation intermediates can compro-
mise the integrity of lipid membranes (Lashuel and Lansbury,
2006). Importantly, these different routes of toxic action are not
mutually exclusive but may operate in parallel.
To investigate the toxicity mechanisms of amyloid-like aggre-
gation, we have established a cellular model based on the
expression of artificial proteins that were designed to form
b sheet structures, and shown previously to self-assemble into
fibrils in vitro (West et al., 1999). The sequences of these proteins
were explicitly designed to contain b strands with an alternating
pattern of polar and nonpolar residues, while the exact identities
of the side chains were varied combinatorially. Similar bipolarCell 144, 67–78, January 7, 2011 ª2011 Elsevier Inc. 67
segments occur in 30% of human proteins, including several
neurodegenerative disease proteins, but are usually buried
within the folded structure (Tartaglia et al., 2008). Because the
model proteins were designed de novo, they are not biased by
the evolutionary burden of natural proteins and thus allowed us
to study the gain-of-function toxicity caused by aggregation
without interference either from loss-of-function alterations or
from an augmentation of the biological activities of natural
disease proteins (Cooper et al., 2006; Lam et al., 2006).
Here, we tested specifically the hypothesis that the aggre-
gates engage in widespread aberrant protein interactions. We
found that expression of the model proteins in human cells
results in aggregate formation and toxicity. Quantitative proteo-
mic analysis reveals that the aggregates interact with and
sequester multiple preexistent and newly synthesized proteins.
Interestingly, these interactions can be explained in terms of
specific sequence features of the coaggregating proteins, such
as their multidomain character and their enrichment in disor-
dered regions, properties that are strongly linked with multifunc-
tionality and the occupancy of hub positions in the cellular
protein network. We suggest that aberrant interactions with
numerous proteins having key cellular functions contribute to
aggregate toxicity.
RESULTS
Designed b Sheet Proteins Are Cytotoxic
To investigate the gain-of-function cytotoxicity associated with
amyloid-like aggregation, we used several model polypeptides
from a combinatorial library rationally designed to form cross-
b fibrils (West et al., 1999). These proteins, henceforth desig-
nated as b proteins, contain six b strands connected by 4-amino
acid linker segments, with each strand comprising seven amino
acids in a polar-nonpolar alternating pattern. An N-terminal
c-Myc-epitope was attached to facilitate detection (Figure 1A).
The three proteins chosen for analysis, b4, b17, and b23, differ
in sequence (pairwise identities of b strands 35%), with b23
having the highest hydrophobic volume and b sheet propensity,
due to its higher isoleucine content (Figure 1A) (Tartaglia et al.,
2008). As a control, we used the designed a-helical protein,
a-S824, which is similar to the b proteins in amino acid compo-
sition but folds into a 4-helix bundle structure (Wei et al., 2003)
(Figure 1A).
Upon dilution from denaturant into physiological buffer, the
purified b proteins adopted b sheet conformation as determined
by CD and rapidly assembled into aggregates detectable with
the amyloid-binding dyes thioflavin T (ThT) andNIAD-4 (Nesterov
et al., 2005) (Figures 1B, 1C, and Figures S1A and S1B available
online). The intensity of ThT and NIAD-4 binding was highest for
b23, followed by b17 and b4 (Figures 1B and 1C), consistent with
the relative b aggregation propensity of these proteins calcu-
lated with the sequence-based Zagg method (Tartaglia et al.,
2008) (Zagg scores are: b4, 0.79; b17, 0.83; b23, 0.93; a-S824,
and 0.30). ANS fluorescence, a probe for exposed hydrophobic
regions, suggested the presence of hydrophobic surfaces on the
aggregates, in particular for b23 and b17 (Figure 1D). As shown
via electron microscopy, the b proteins formed mostly relatively
short protofilaments (2–3 nm in diameter) as well as more68 Cell 144, 67–78, January 7, 2011 ª2011 Elsevier Inc.heterogeneous, globular aggregates (Figure 1E). Formation of
globular species was most pronounced with b23 (Figure 1E).
Similar prefibrillar aggregates are also observed with natural
amyloidogenic proteins and correlate with cytotoxicity (Bolog-
nesi et al., 2010; Campioni et al., 2010; Chiti and Dobson,
2006). In contrast, in low-salt buffer (pH 6), the b proteins formed
thicker (10–12 nm diameter) and longer fibrils (Figure 1F) with
FTIR spectroscopic properties characteristic of amyloid (Fig-
ure S1C). Thus, the model proteins undergo amyloid-like aggre-
gation in vitro, and in physiological buffer populate prefibrillar
species.
Upon expression in HEK293T cells for 3 days, the b proteins,
but not a-S824, reduced cell viability substantially, as measured
by theMTT assay (Figure 2A), and induced cell death in the order
b23 > b17 > b4 (Figures S2A and S2B). Cell viability was less
impaired after 24 hr of expression, without a significant differ-
ence in toxicity between the three b proteins (Figure 2A). Upon
cell fractionation, the b proteins were largely recovered in the
insoluble fraction, whereas a-S824 was soluble (Figure 2B).
Note that b4 and b17 migrated on SDS-PAGE more slowly
than expected, but this difference was not observed in urea/
SDS gels (Figure S1A). Confocal immunofluorescence micros-
copy with anti-Myc antibody showed that the b-protein-express-
ing cells adopted a collapsed shape lacking filopodia (Figure 2C).
Aggregates accumulated mostly in the perinuclear space and
the nuclei were often deformed. The aggregates were NIAD-4
positive (Figure 2D), suggesting the presence of amyloid-like
material. To detect oligomeric aggregation intermediates, cell
extracts were fractionated by size exclusion chromatography
followed by dot blot analysis with the A11 antibody, which was
raised against the Alzheimer Ab peptide and preferentially
recognizes amyloid oligomers associatedwith cytotoxicity, inde-
pendent of amino acid sequence (Kayed et al., 2003). b23
expression generated substantially higher levels of A11 reactive
material than expression of b4 and b17 (Figure 2E and Fig-
ure S2C), consistent with the greater toxicity of b23 and its
pronounced tendency to form prefibrillar aggregates in vitro
(Figures 1E and 1F).
In summary, the designed b proteins resemble amyloidogenic
disease proteins in terms of aggregation properties and toxicity
and allow us to investigate the mechanism of gain-of-function
toxicity independently from evolved biological interactions.
Identification of the b Protein Interactome
Gain-of-function toxicity of aggregation may arise, at least in
part, from aberrant interactions of the aggregates with cellular
proteins. To test this hypothesis, we performed a sensitive,
quantitative proteomic analysis of the b protein interactome
using SILAC (stable isotope labeling with amino acids in cell
culture) (Ong and Mann, 2006) and peptide identification by
tandem mass spectrometry (LC-MS/MS). These experiments
were performed at 24 hr after b protein transfection when cell
viability was not yet severely impaired (Figure 2A). In one set of
experiments, cells labeled with light (L), medium (M) or heavy
(H) arginine and lysine isotopes were transfected with empty
vector, a-S824 and b23, respectively. In another set-up,
a-S824, b4, and b17 were expressed in L-, M-, and H-labeled
cells, respectively (Figure 3A). Preferential interactions with b4,
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Figure 1. Amyloidogenic Aggregation of Model Proteins In Vitro
(A) Sequences of the model proteins, b4, b17, and b23, designed to form b-sheet fibrils, and a-S824 designed to form a 4-helical bundle. Polar and nonpolar
amino acids are indicated in gray and yellow, respectively, b strands and a helices by blue arrows and rods respectively. N-terminal c-Myc tags are shown in red.
(B–D) Tinctorial properties of b protein aggregates. The purified proteins indicated (3 mM) were analyzed in 25 mM HEPES buffer (pH 7.5), 150 mM KCl, 0.5 mM
MgCl2-containing 20 mM Thioflavin T (B), 1 mM NIAD-4 (C), or 20 mM ANS (D). Fluorescence was recorded as described in Experimental Procedures.
(E and F) Transmission electron microscopy of aggregates formed by b4, b17 and b23, as above, at pH 7.5 (E) or 10 mM potassium phosphate (pH 6.0) (F).
Proteins were negatively stained and observed at a magnification of 55,0003.
See also Figure S1.b17, or b23 were explored in a third type of experiment. Total cell
lysates were prepared essentially without removal of aggregate
material and combined 1:1:1 (Figure 3A and Figure S3A). The
expressed proteins were quantitatively isolated using anti-Myc
antibody coupled to magnetic beads, followed by SDS-PAGE,
in-gel digestion, and LC-MS/MS analysis.
It seemed plausible that initial coaggregation may be driven by
relatively weak interactions, which might introduce a stochastic
element in the proteomic analysis. To overcome this problem
we based our analysis on extensive biological repetitions of theexperiments. Three proteomic experiments were performed,
each consisting of three biological repeats (independent trans-
fections). A protein was identified as b protein interactor
when its isotope-labeled peptides were either enriched relative
to the a-S824 control or relative to one of the other b proteins
with > 95% confidence in at least two of the three repeats of
a set (see Extended Experimental Procedures and Figures
S3B–S3D). A total of 94 interactors of b23, 73, of b17 and 57 of
b4 were identified in experiments of equivalent sampling size,
consistent with the relative toxicity of the proteins (Figure 3BCell 144, 67–78, January 7, 2011 ª2011 Elsevier Inc. 69
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Figure 2. Cytotoxicity and Aggregation of
Model Proteins in HEK293T Cells
(A) Viability of HEK293T cells expressing b4, b17,
b23, and a-S824 measured by MTT assay 24 hr
and 72 hr after transfection. MTT reduction by
control cells transfectedwith empty vector, C, was
set to 100%. Standard deviations were derived
from at least three independent experiments.
(B) Solubility of b4, b17, b23, and a-S824 analyzed
by fractionation of lysates from cells 24 hr after
transfection by centrifugation and immunoblotting
with anti-Myc antibody. T, total lysate; S, soluble
fraction; P, pellet fraction; C, empty vector control.
Representative results from at least three inde-
pendent experiments.
(C and D) Protein distribution and aggregation in
intact cells expressing a-S824, b4, b17, and b23.
After 24 hr, proteins were detected by immuno-
fluorescence with anti-Myc antibodies (C). DIC,
differential interference contrast images. Amyloid-
like aggregates were detected by staining with
NIAD-4 (D) (see Experimental Procedures). Nuclei
were counterstained with DAPI. The scale bar
represents 20 mm. Representative images of three
independent experiments.
(E) Quantification of A11 antibody reactivity in
extracts from b-protein-expressing cells 24 hr
after transfection. The cumulative dot blot signal of
fractions from size exclusion chromatography was corrected for the cumulative anti-Myc signal, indicating the amounts of a-S824, b4, b17, and b23, and
expressed relative to the A11 reactivity in a-S824 expressing cells (set to 1) (see Figure S2C for original data). Averages and standard deviations represent at least
three independent experiments.
See also Figure S2.and Tables S1–S3). Only four proteins were marginally enriched
on a-S824 relative to the vector only control, including two ribo-
somal proteins (Figure S3B). Approximately 60% of the b4 and
b17 interactors were also found to interact with b23, indicating
a high degree of overlap in interaction profiles (Figure 3B).
Western blotting of pulldowns and immunofluorescence analysis
of cells confirmed the results from SILAC/MS for several interac-
tors (Figures S3E and S3F). Thus, interactions of the b protein
aggregates with multiple endogenous proteins precede the
strong decrease in cell viability observed at 72 hr after transfec-
tion (Figure 2A).
As summarized for b23, most of the proteins associated with
the aggregates have their primary location in the cytoplasm,
nucleus and mitochondria (Figure 3C and Table S1). Proteins
involved in chromatin regulation, RNA processing, transcrip-
tion, translation, cytoskeletal function, vesicle transport, and
protein quality control were highly represented. These proteins
are generally of average cellular abundance (Su et al., 2002)
and for several of them between 10% and 45% of total was
associated with the aggregates, based on depletion from
supernatant fractions after pulldown as measured by SILAC/
MS (Table S1 and Extended Experimental Procedures). Note
that this analysis probably underestimates the extent of
sequestration, since coaggregates may partially dissociate
during isolation. Interestingly, 12 different translation initiation
factors interacted directly or indirectly with the aggregates,
including 9 of the 13 subunits of the eIF3 complex and 3
subunits of eIF4 (Figure 3C). b17 aggregates contained 10
and b4 aggregates 9 of these proteins (Tables S2 and S3).70 Cell 144, 67–78, January 7, 2011 ª2011 Elsevier Inc.Immunofluorescence analysis demonstrated extensive co-
localization of eIF3D and eIF4GII with the aggregates and
western blotting of pulldowns confirmed that at least 10%
of cellular eIF3D coaggregated with b23 and b17, compared
to 6% with b4 (Figures S3E and S3F, and data not shown).
Indeed, labeling experiments showed that cells expressing
b23 for 24 hr had a 35% reduced protein synthesis capacity
(Figure S3G). Similarly, the altered morphology of b-protein-
expressing cells revealed by actin staining (Figure S3H) may be
attributed to the association of filamins A, B, C, (FLNA, FLNB,
FLNC), and the giant protein plectin-1 (PLEC1) (500 kDa)
with the aggregates (Figure 3C), proteins that are critical for
the formation and maintenance of cytoskeletal architecture.
These results show that many different proteins, involved in
a range of essential cellular functions, are affected by the
b protein aggregates.
Aberrant Stress Response in b-Protein-ExpressingCells
The proteomic analysis identified several cytosolic chaperones
and chaperone regulators to be associated with the aggregates,
including Hsc70 (Hsc71) and its cochaperones Hsp110
(Hsp105), Hdj1/2 and Bag2, as well as the nascent chain associ-
ated complex, NAC (Figure 3C). Hsp110 was enriched in the
aggregates in a manner correlating with the relative toxicity of
b4, b17 and b23, as confirmed by western blotting and immuno-
fluorescence (Figures 4A and 4B). Indeed, overexpression of
Hsp110 (Figure S4A) partially suppressed b4 and b17 aggrega-
tion and toxicity but was inefficient in mitigating the toxic effects
of b23 (Figures 4C and Figures S4B and S4C).
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Figure 3. Interactome Analysis of b proteins
(A) Design of SILAC experiments to identify b protein interactors by LC-MS/MS. L, M, and H, light, medium, and heavy isotope media. C, vector only control.
(B) Overlap between the interactor sets of b4, b17, and b23. Total numbers of identified interactors are given in parentheses.
(C) The b23 interacting proteins are grouped according to cellular location and function.
See also Figure S3 and Tables S1–S3.Remarkably, expression of the b proteins did not induce the
cytosolic stress response or heat-shock response (HSR), as no
increase in the levels of Hsp110, Hsp70, or Hsp27 was observed
(Figures 4A and data not shown). A possible defect in the HSR
was further analyzed using a luciferase reporter gene under
control of the HSF1-dependent Hsp70 promoter (Williams
et al., 1989). While inhibition of proteasome function by MG132
in control cells resulted in a 5-fold induction of the reporter,
this induction was completely abolished in cells expressing the
b proteins for 24 hr (Figure 4D). The phorbol-12-myristate-13-
acetate (PMA)-mediated induction of a luciferase reporter under
the NF-kB promoter was also impaired, but to a lesser extent
than the inhibition of the stress response (Figure 4E). Thus,
expression of the model b sheet proteins leads to a deficiency
of the normal cytosolic stress response, thereby limiting the
capacity of cells to mount an effective defense.Structural Features of b Protein Interactors
A bioinformatic analysis of the physicochemical properties of the
b protein interactors was conducted to see whether these
proteins share certain structural features. We focused our initial
analysis on the interactors of b23 (Table S1). Compared to a set
of 3055 control proteins identified by LC-MS/MS in a total cell
lysate (Table S4), the b23 interactors are shifted to higher molec-
ular weight, with a significantly greater fraction of proteins above
150 kDa (p < 0.005) (Figure 5A). In addition, the interactors have
a lower average hydrophobicity and a bimodal hydrophobicity
distribution (Kyte and Doolittle, 1982) (p < 0.005) (Figure 5B).
The occurrence of domain folds among the b23 interactors, as
classified in SCOP, was generally similar to that of lysate
proteins. However, the b23 interactors contained significantly
more proteins with all beta domains (SCOP class b) (p < 0.05)
(Figure S5A), including the beta-barrel VDAC proteins of theCell 144, 67–78, January 7, 2011 ª2011 Elsevier Inc. 71
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Figure 4. Impairment of the Stress
Response in b-Protein-Expressing Cells
(A and B) Association of Hsp110 with b protein
aggregates. HEK293T cells were transfected as
indicated (C, empty vector control). 24 hr after
transfection, Myc-tagged proteins b4, b17, b23,
and a-S824 were immunoprecipitated from cell
lysates and analyzed by immunoblotting with anti-
HSP110 antibody (A). Lysate samples correspond
to 8% of input used for IP. b4, b17, and b23 in
pulldowns was associated with 5%, 9%, and
16% of total cellular Hsp110, respectively (also
see Figure S3F). For immunofluorescence analysis
(B), cells were fixed and costained with anti-Myc
antibodies and anti-Hsp110 antibodies. Nuclei
were stained with DAPI. Representative examples
of three independent experiments are shown.
(C) Partial rescue of b protein toxicity by Hsp110
overexpression. Cells were transfected with
empty vector or the expression vector for human
Hsp110. 24 hr later, cells were electroporated with
empty vector, C, or expression vectors for b4, b17,
b23, and a-S824. Three days after the second
transfection, MTT assays were performed. Empty
vector control was set to 100% viability. Standard
deviations of three independent experiments are
shown.
(D and E) Inhibitory effect of b proteins on
cellular stress response pathways. Cells were
cotransfected with HSP70-luciferase reporter (D)
or NF-kB-luciferase reporter constructs (E) and
the b-protein-expressing plasmids. 6 hr later, 5 mM
MG132 (D) or 16 mMPMA (E) were added to induce
the respective promoter. Luciferase activity was
measured 24 hr after transfection. The promoter
activity in cells transfected with control vector, C,
without inducer was set to 1. Standard deviations
of three independent experiments are shown.
See also Figure S4.outer mitochondrial membrane and the filamins which have
Ig-domain repeats (Table S1 and Figure S3F).
The lower hydrophobicity of many interactors suggested that
these proteins may be rich in intrinsically unstructured regions
(IURs). Indeed, compared to lysate proteins, the b23 interactors
have a significantly greater fraction of total amino acids in IURs
(p < 0.05), based on the DisoDB database (Pentony and Jones,
2009) and the DisEMBL and IUPred prediction tools for unstruc-
tured regions (Dosztanyi et al., 2005; Linding et al., 2003) (Fig-
ure 5C, Tables S1 and S4, and data not shown). Pronounced
differences emerged when considering the fraction of proteins
with IURs longer than 30 or 50 residues (Figure 5D). For example,
60%of the b23 interactors are predicted to contain at least one
unstructured segment of 30 amino acids, compared to 45% in
lysate proteins or the complete proteome (p < 0.005) (Figure 5D).
The corresponding numbers for IURs > 50 amino acids are
40% and 25% (p < 0.005), respectively. Moreover, the b23
interactors contain on average 3 disordered segments of 30
amino acids (compared to 1.8 for the lysate proteins, p <
0.005). The predicted IURs of the interactors are shifted to
greater length (p < 0.005) (Figure S5B and Tables S1 and S4),
with 21% of the proteins containing IURs > 80 amino acids72 Cell 144, 67–78, January 7, 2011 ª2011 Elsevier Inc.and 10% of 100 to 429 residues. The IURs are enriched in polar
amino acids and in amino acids that have a high propensity to
form coil and turn regions, such as M, K, R, E, S, Q, and P,
and are depleted in aromatic and hydrophobic amino acids W,
Y, F, C, I, and V (Dunker et al., 2008). Such sequences are struc-
turally flexible and populate a range of conformational states
from extended disordered to collapsed, molten globule-like
structures (Dunker et al., 2008; Pentony and Jones, 2009). Using
the Zagg algorithm to predict aggregation propensities, the b23
interactors have higher aggregation scores than lysate proteins
(see Figure S6B below).
A comparison of the proteins that interact preferentially with
b4, b17, and b23 (18, 28, and 27 proteins, respectively), as
defined by the SILAC experiments (Figure S3D and Extended
Experimental Procedures), revealed that a gradual increase in
molecular weight and decrease in hydrophobicity of the interac-
tors, along with a slight increase in their disorder, correlated with
the differential cytotoxicity of the three b proteins (Figure 5E).
This trend was also observed when comparing the complete
interactor sets of the three b proteins (Tables S1–S3).
The prominent association of proteins with low hydropho-
bicity and high intrinsic disorder with the aggregates was
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Figure 5. Structural Properties of the
b Protein Interactors
(A and B) Distribution of molecular weight (A) and
average hydrophobicity (B) of lysate proteins
(gray) and b23 interactors (red) (Tables S1 and S4).
Box plots (insets) indicate the distribution of the
data. Dashed horizontal line indicates the median,
whisker caps and circles indicate 10th/90th and
5th/95th percentiles, respectively. P values are
based on Mann-Whitney test.
(C andD) Disorder analysis of b protein interactors.
Percentage of disordered residues in interactor
sequences (C). p value based on Mann-Whitney
test. Fraction of proteins with disordered stretches
longer than 30 or 50 amino acids (D). **p < 0.005
based on a chi-square test. Disorder was deter-
mined using DisoDB.
(E) Structural properties of lysate proteins and of
proteins interacting preferentially with b4, b17, or
b23.
See also Figure S5 and Tables S1–S6.unexpected. To test whether such proteins are targeted more
generally by amyloid-like aggregation, we performed an initial
analysis of interactors of wild-type Ab1-42 and its Arctic mutant
(E22G), which causes early-onset Alzheimer’s disease. The
latter was included because it is known to populate higher
levels of prefibrillar aggregates and toxic oligomers exposing
hydrophobic surfaces (Bolognesi et al., 2010; Nilsberth et al.,
2001). To allow a comparison with the model b aggregates,
the Ab proteins were also expressed in the cytosol, using
GFP fusions (Kim et al., 2006). In contrast to the artificial
b proteins, the Ab constructs were degraded but accumulated
upon partial proteasome inhibition with MG132 (Figure S5C)Cell 144, 67–(Lee et al., 2006). The Arctic mutant
formed visible aggregates more readily
and showed substantially greater toxicity
than WT Ab142 (Figures S5D and S5E).
Analysis by SILAC/MS revealed that
the Ab interactome is comparable in
complexity to that of the b proteins,
with a direct overlap of 25%, promi-
nently including translation initiation
factors, chromatin regulators, RNA pro-
cessing proteins, mitochondrial mem-
brane proteins and chaperones (Table
S5). We also identified 31 proteins which
were enriched on the Arctic mutant rela-
tive to the less toxic Ab142 WT (Table
S6). Notably, these proteins resemble
the b protein interactors in physico-
chemical properties and are significantly
enriched in IURs (p < 0.05) (Figures
S5F–S5I).
From these results, we conclude that
cells contain a subpopulation of meta-
stable proteins that are prone to interact
with and potentially become sequesteredby toxic species populated in the process of amyloid-like
aggregation.
b Protein Interactors Include Pre-Existent and Newly
Synthesized Proteins
While the results above suggested that structural flexibility is crit-
ical in facilitating the interaction of endogenous proteins with the
b aggregates, we noted that for 40% of the b23 interactors no
IURs > 30 amino acids are predicted (Figure 5D and Table S1).
We therefore considered the possibility that some of these
proteins may succumb to coaggregation upon synthesis
before adopting stably folded structures. To test this idea, we78, January 7, 2011 ª2011 Elsevier Inc. 73
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Figure 6. Newly Synthesized and Pre-Exis-
tent b Protein Interactors
(A) Design of SILAC based mass spectrometric
analysis to identify proteins preferentially inter-
acting with b23 as newly synthesized (new) or
preexistent (old) proteins (Pulse-SILAC).
(B) Ratios of heavy to medium isotopes (H/M) of
b23 interactors relative to the H/M ratios for the
same proteins in the total cell lysate (see Extended
Experimental Procedures). The log of this ratio of
ratios increases with the tendency of a protein to
interact with b23 as a new protein.
(C and D) Disorder analysis of new and old b23
interactors. Percentage of disordered residues
in interactor sequences (C). p value is based
on Mann-Whitney test. Fraction of proteins with
continuous disordered stretches > 30 or > 50
amino acids (aa) (D). **p < 0.005 for old interactors
relative to lysate (see Figure 5D), based on Chi-
square test.
(E) Molecular weight, disorder and hydrophobicity
of old and new b23 interactors relative to lysate
proteins.
See also Figure S6 and Tables S4 and S7.pulse-labeled HEK293T cells expressing b23 or a-S824 with
35S-methionine, followed by immunoisolation of the proteins.
Around 7% of the proteins labeled within 15 min were coisolated
with b23, compared to only1%with a-S824 (Figure S6A), sug-
gesting that a substantial fraction of newly synthesized polypep-
tides can interact with b23.
To identify such proteins, we performed pulse-SILAC experi-
ments. Cells were cultured with medium amino acid isotopes
(M) to label preexistent proteins, followed by transfection with
b23. The culture was divided and one half was immediately
shifted to media containing heavy amino acid isotopes (H).
Control cells were cultured with light amino acids (L) and trans-
fected with a-S824. After 24 hr, the cells from the three condi-
tions were combined and subjected to anti-Myc pulldown and
LC-MS/MS analysis (Figure 6A). The H/M isotope ratio of the
b23 interactors in the pulldown relative to their H/M ratios in
the lysate was used to indicate whether they interact with b23
preferentially as newly synthesized (New) or pre-existent (Old)
proteins (Figure 6A). H/M labeling ratios were obtained for 50
b23 interactors, and a number of these showed a clear prefer-
ence for interaction soon after synthesis (Figure 6B and Table
S7). In contrast, fewer proteins interacted preferentially as old
proteins. These interactors include Hsp110 as well as several74 Cell 144, 67–78, January 7, 2011 ª2011 Elsevier Inc.translation initiation factors (Table S7),
consistent with impairment of translation
efficiency being an early consequence
of b protein toxicity (Figures S3E–S3G).
Interestingly, the old and new interac-
tors from the ends of the distribution (15
proteins each) differ markedly in their
structural properties. The old interactors
contain a significantly greater fraction of
amino acids in IURs than the new interac-
tors (Figure 6C). They are strongly en-riched in continuous disordered regions (Figure 6D) and are of
low average hydrophobicity (Figure 6E). In contrast, the new
proteins are similar to lysate proteins in terms of hydrophobicity,
but are lower in disorder and substantially larger in size (Fig-
ure 6E). Their folding pathways may be complex and kinetically
slow, possibly resulting in the prolonged exposure of hydro-
phobic residues during folding. Based on analysis using the
Zagg algorithm, the new b23 interactors show high intrinsic
aggregation scores only in their unfolded states (Figure S6B).
In contrast, the old interactors are highly flexible and are unable
to bury aggregation-prone regions in their native structures.
Thus, these proteins have high aggregation scores both in their
unfolded and folded states (Tartaglia et al., 2008) (Figure S6B).
Some of them may coaggregate as preexistent or newly synthe-
sized proteins, consistent with their lower peak values in the
isotope labeling ratios compared to the new proteins (Figure 6B).
In summary, the b23 interactors can be divided into two over-
lapping subsets of relatively aggregation-prone proteins: One
group is enriched in IURs, which would be prone to aggregate
even in their post-folding state. This group is highly represented
among the old proteins. The second group contains an abun-
dance of large and/or multidomain proteins, which require longer
times for synthesis and may fold slowly. Consequently, in
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Figure 7. Mechanism of b Aggregation
Toxicity
(A and B) Functional context of b protein inter-
actors within the protein interaction network.
Shown in (A) are the average number of functional
interactions of the b23 interactors in comparison
to proteins in the HPRD database and in the
experimentally determined cell lysate (3000
proteins). These functional interactions are cate-
gorized into total interactions, interactions with
essential proteins and interactions with proteins
involved in neurodegenerative disease (Ray-
chaudhuri et al., 2009). In (B), the complete sets of
b4, b17, and b23 interactors are compared in
terms of these functional properties.
(C) Model for the interaction of b aggregates with
pre-existent and newly synthesized proteins. Pre-
existent proteins are structurally flexible in their
functional state and are involved in multiple
protein-protein interactions, which may be dis-
rupted by their association with the b aggregates.
The newly synthesized proteins are structurally
vulnerable to coaggregation during folding and
assembly. Interaction of both the preexistent
and newly synthesized proteins with the b aggre-
gates is facilitated by the limiting capacity of
chaperones to shield aggregate surfaces and by
the failure of the cells to mount an efficient stress
response.conditions of limited chaperone capacity, they would be prone to
aggregate during and shortly after synthesis. This group is
enriched among the newly synthesized proteins. Finally, some
proteins occupy a transition zone, combining physicochemical
features of both groups.
Aggregate Interactors Have Critical Network Functions
The structural flexibility and relatively large size of the aggregate
interactors suggests that these proteins may normally be
involved in numerous functional protein interactions. To address
this possibility, we analyzed how the b23 interactors are linked
with the cellular protein network. A query of the Human
Proteome Reference Data Base (HPRD) (Keshava Prasad
et al., 2009) revealed that each of these proteins functionally
interacts with 12 different proteins on average, compared to
7 per lysate protein and 7.5 per protein in HPRD (19,651
entries) (Figure 7A). Notably, most of the b23 interactors have
no or only few interactions with any of the other b23 interactors,
suggesting that coaggregation may disrupt their functional
complexes. For example, the microfilament protein vimentin
interacts with more than 100 different proteins according to
HPRD, but only three of those are among the identified b23 inter-
actors, although 49 potential vimentin interactors were detected
in the lysate or background of the pulldowns (data not shown).
Essential proteins often occupy critical ‘‘hub’’ positions in the
network (Haynes et al., 2006; Jeong et al., 2001). Each b23 target
protein interacts on average with 5 different essential proteins,
compared to only 3 per lysate protein and 1.5 per entry in
HPRD (Figure 7A). Moreover, the b23 interactors are more
frequently linked than lysate proteins, through direct interac-
tions, with proteins that have been found in association withneurodegenerative disease proteins (Raychaudhuri et al., 2009)
(Figure 7A and Table S1).
Assuming that a disturbance of functional protein interactions
contributes critically to b aggregation toxicity, b23 would be
expected to differ in this regard from the less cytotoxic proteins
b4 and b17. We found that the b4, b17 and b23 interactors are
physically linked to a total of 600, 643, and 912 different proteins,
including 216, 213, and 340 essential proteins and 53, 56, and 84
proteins associated with neurodegenerative disease networks,
respectively (Figure 7B). Thus, the capacity of the b protein
aggregates to interact with and sequester highly connected
cellular proteins correlates well with their relative cytotoxicity.
DISCUSSION
Widespread Coaggregation of Metastable Proteins
A key finding of this study is that amyloidogenic aggregation can
result in the sequestration of numerous proteins that share
distinct physicochemical properties: They are relatively large in
size and exhibit high structural flexibility, with a significant
enrichment in disordered regions, features that are strongly
linked with multifunctionality (Figure 7C).
The artificial b sheet proteins used as a model were designed
to assemble into fibrils (West et al., 1999). Like natural amyloido-
genic proteins, they populate a range of prefibrillar aggregation
intermediates, which are likely to represent the primary toxic
agents in aggregation diseases (Chiti and Dobson, 2006; Jahn
and Radford, 2008). Based on recent findings, the proteotoxicity
of such species correlates with the exposure of ANS-binding
hydrophobic surfaces (Bolognesi et al., 2010; Campioni
et al., 2010) and reactivity with the A11 anti-oligomer antibodyCell 144, 67–78, January 7, 2011 ª2011 Elsevier Inc. 75
(Kayed et al., 2003), properties that are reproduced by themodel
proteins. Flexible hydrophobic surfaces and unpaired backbone
structure that is not yet integrated into a stable cross-b core
(Mossuto et al., 2010) may endow oligomers and protofilaments
with the capacity to engage in widespread aberrant interactions
with metastable proteins. Whether oligomeric species with
similar interaction properties also occur during nonamyloido-
genic aggregation, leading to amorphous structures rather
than fibrils, remains to be determined.
The b protein aggregates were found to interact with preexis-
tent and newly synthesized polypeptides (Figure 7C). The former
are strongly enriched in intrinsically unstructured regions (IURs)
and are of lower average hydrophobicity. A similar trend was
observed for interactors of the toxic aggregates of the Arctic
mutant of Ab1-42, which is known to transiently populate high
concentrations of prefibrillar aggregates (Bolognesi et al.,
2010) (Figures S5C–S5I). Proteins rich in structural disorder are
considered to be adaptable to multiple interaction partners
(Dunker et al., 2008; Pentony and Jones, 2009). On the other
hand, local structural fluctuations in these proteins are expected
to give rise to the exposure of sequence elements with a higher
propensity to form aggregates, consistent with the relatively high
Zagg scores of the b protein interactors (Tartaglia et al., 2008).
Indeed, some of the best known neurodegenerative disease
proteins, such as a-synuclein or tau, are thought to be almost
entirely unstructured. In contrast, the proteins that interact with
the aggregates during or soon after synthesis have average
hydrophobicity and disorder. These proteins tend to be large in
size and are likely to populate nonnative states which expose
hydrophobic surfaces during their folding, assembly or transport
that must be shielded by molecular chaperones (Figure 7C). For
example, among the b protein interactors are mitochondrial
membrane proteins such as VDAC and the ADP/ATP translocase
which require chaperone protection during post-translational
sorting (Young et al., 2003).
By targeting flexible regions and hydrophobic surfaces of
preexistent and newly synthesized proteins, the b protein aggre-
gates may act in a ‘chaperone-like’ manner but cannot promote
folding through regulated release. Consequently, more andmore
proteins are recruited, which in turn may generate new interac-
tion surfaces, thereby magnifying the toxic potential of the
aggregates (‘snowball effect’).
Interference with Multiple Key Cellular Functions
The b protein interactors include many proteins with key cellular
functions in transcription and translation, chromatin regulation,
vesicular transport, cell motility and architecture, as well as
protein quality control (Figure 3C). Similar proteins were also
found to interact with aggregates of Ab (Table S5), suggesting
that these pathwaysmay bemore generally at risk in aggregation
disorders. Bioinformatic analysis showed that most of the coag-
gregating proteins have numerous functional interactors, consis-
tent with their preferential role as network hubs (Haynes et al.,
2006; Jeong et al., 2001). The number of functional interactions
of the sequestered proteins correlates with the relative cytotox-
icity of the b protein aggregates (Figure 7B). It is thus likely that
the aggregates compete for binding to disordered regions with
a protein’s normal interactors and the more toxic forms may be76 Cell 144, 67–78, January 7, 2011 ª2011 Elsevier Inc.able to compete more effectively. Based on our proteomic
and biochemical measurements, 10%–45% of total may be
sequestered for several of the interacting proteins (Figures
S3E–S3F and Table S1). Moreover, certain proteins may misfold
upon interaction with the aggregates but remain in solution.
Thus, dependent on the interaction strength of the aggregates,
an increasing number of key functions may be affected, eventu-
ally resulting in fatal network collapse. We estimate that the
human proteome contains 2000 proteins that structurally
resemble the experimentally identified b aggregate interactors.
Dependent on cell type and the exact structural properties of
the causative aggregate, different subsets of these proteins
may be affected, which may help to explain different patterns
of pathobiology. It will be interesting to see which of these
proteins are preferentially targeted by b aggregates in neuronal
cells.
Our results also lend support to the recent view that protein
misfolding and aggregation disturbs proteostasis by compro-
mising the cellular folding environment (Morimoto, 2008). We
suggest that the association of endogenous proteins with the
aggregates is facilitated by the failure of the affected cells to
mount an efficient stress response, a phenomenon that was
previously observed during prion infection (Tatzelt et al., 1995)
and may be particularly serious in postmitotic cells, such as
neurons. Inhibition of the stress response may be due to the
sequestration by the aggregates of multiple chromatin regula-
tors, which interact with numerous transcription factors,
including HSF1 (Erkina et al., 2010; Sullivan et al., 2001). As
a consequence of limiting proteostasis capacity, newly synthe-
sized polypeptides with a high chaperone requirement for folding
may become increasingly vulnerable to sequestration by disease
protein aggregates (Figure 7C). This fatal chain of events may be
further enhancedduring aging, which is associatedwith a decline
of proteostasis and thus would result in a reduced capacity of
cells to protect their more vulnerable proteins against coaggre-
gation (Balch et al., 2008; Morimoto, 2008).
EXPERIMENTAL PROCEDURES
Protein Purification and In Vitro Analysis of Aggregates
Proteins a-S824, b4, b17 and b23 were expressed in E. coli BL21 cells and
purified as described in Extended Experimental Procedures. Fluorescence
analysis, circular dichroism, FTIR spectroscopy and negative stain electron
microscopy of the aggregates were performed using standard methods (see
Extended Experimental Procedures).
Cell Culture, Immunoblotting and Reporter Assays
HumanHEK293T cells were cultured under standard conditions (see Extended
Experimental Procedures). Transient transfections were performed by electro-
poration with 30 mg expression vector or by Lipofectamin (Invitrogen) transfec-
tion for overexpression of Hsp110. Immunoblots were developed using the
chemiluminescence kit Rodeo ECL (USB) and analyzed using a LAS-3000
image reader (Fujifilm) and the AIDA software (Raytest). For luciferase reporter
assays, cells were lysed in Lysis Buffer (Promega) and luciferase activity
measured using a Lumat LB9507 (EG&G Berthold).
Cell Viability
Cell viability was analyzed by measuring the capacity of cells to reduce 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) to formazan
at different times after transfection with a-S824, b protein or Ab42-GFP
constructs (Shearman, 1999).
Solubility Analysis and Oligomer Quantification
Cells were lysed in Triton X-100/Na deoxycholate-containing PBS with
protease inhibitors. Benzonase was used to hydrolyze DNA. Raw debris was
removed at 20003 g for 5 min and the supernatant was fractionated by centri-
fugation (100.000 3 g, 30 min) into pellet and soluble fractions or by gel filtra-
tion on a Superose 6 column (Amersham Bioscience), followed by dot blot
analysis with anti-oligomer antibody A11 (Kayed et al., 2003) (see Extended
Experimental Procedures for details).
Immunofluorescence and Fluorescence Imaging
Transfected cells were fixed with paraformaldehyde, permeabilized with Triton
X-100 and stained with antibodies as indicated. Images were recorded with
a Leica TCS SP2 confocal laser scanning microscope. Protein aggregates
were analyzed by staining with NIAD-4 (ICX Nomadics) (see Extended Exper-
imental Procedures).
SILAC and Sample Preparation for LC-MS/MS Analysis
Labeling of cells was performed in custom medium supplemented with light
(L), medium (M) or heavy (H) arginine and lysine isotopes (see Extended Exper-
imental Procedures). In pulse-SILAC experiments, M-labeled cells were
shifted to H-medium, as indicated in Figure 6A. Cells were lysed and cell debris
removed by low-speed centrifugation (20003 g, 5 min). Lysates from L, M and
H cells were adjusted to equal protein concentration andmixed at a 1:1:1 ratio.
An aliquot of this mix was set aside as ‘‘lysate’’ control. Anti-Myc or anti-GFP
MicroBeads (Miltenyi Biotech) were used to isolate the Myc-tagged proteins
or GFP-fusion proteins and their interactors. The bound proteins were eluted
and processed as described (Ong and Mann, 2006). The spectra were
interpreted using MaxQuant version 1.0.12.31 (Cox and Mann, 2008)
combined with Mascot version 2.2 (Matrix Science, www.matrixscience.
com). See Extended Experimental Procedures for details. The raw MS data
along with a full list of identified proteins and quantitations is available at
https://proteomecommons.org/tranche, entering the following hash: +Ff0/
p8lSBrrzCKZfzAwYS3+Bqw5fonokB679f136te2iklhHtFMUpeT5SM/I3XuufTyr
Xj0ycVVC6G4Li/L02 dA4jcAAAAAAABVfg = =.
Bioinformatic Analysis
Average hydrophobicity was calculated according to Kyte and Doolittle (1982),
protein disorder using the DisoDB database (Pentony and Jones, 2009) and
aggregation propensities according to Tartaglia et al. (2008). Protein fold
prediction and the analysis of functional protein interactions are described in
Extended Experimental Procedures. Student’s t test and Mann-Whitney test
were used to compare groups. Chi-square tests were used to determine signif-
icant differences between categorical data.
SUPPLEMENTAL INFORMATION
Supplemental information includes Extended Experimental Procedures,
six figures, and seven tables and can be found with this article online at
doi:10.1016/j.cell.2010.11.050.
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